Retrospective analysis of mediastinal tumors in childhood

Authors

  • Ali E. Çetinkol Department of Public Health, Izmir Provincial Directorate of Health, Izmir, Turkey

DOI:

https://doi.org/10.18203/issn.2454-2156.IntJSciRep20231446

Keywords:

Mediastinal tumor, Childhood, Follow-up

Abstract

Background: The aim of this study was to determine etiologic distribution, epidemiologic properties, treatment, clinical course and late effects of the treatment of the patients diagnosed with mediastinal tumor.

Methods: Patients under 18 years old diagnosed with mediastinal tumors between January 1990 and June 2011 at the 19 Mayis university department of child oncology were examined retrospectively.

Results: There were 50 (61%) males, 32 (39%) females with mediastinal tumor. Median age at diagnosis was 9.28 years (30 days-17.4 years). Most common symptoms were respiratory distress (29.2%) and cough (23.1%). Sixty eight cases (82.9%) were malignant. Two cases died before diagnosis. Thirty seven cases (45.1%) were located in anterior followed by 16 (19.5%) in middle and 23 (28%) in posterior mediastinum. Most common malignant tumors were lymphomas (n=46, 67.6%), followed by sarcomas (n=12, 17.6%), neural crest tumors (n=8, 11.8%) and germ cell tumors (n=2, 2.9%). Thirteen cases had vena cava superior syndrome and 4 cases had signs of spinal cord compression at the time of diagnosis. Forty eight cases (58.5%) were alive and symptom free on follow-up (mean 39.5 months, 3-139 months), and 22 (26.8%) were died. Sixteen cases (23.5%) had late effects. Overall survival for all malignant tumors were 60.5±7.8%.

Conclusions: Mediastinal tumors should be considered in children with acute progressive respiratory distress and cough. Early diagnosis is still most important factor for prognosis.

Metrics

Metrics Loading ...

References

Bhakta N, Force LM, Allemani C, Atun R, Bray F, Coleman MP et al. Childhood cancer burden: a review of global estimates. Lancet Oncol. 2019;20(1):e42-53.

WHO. International Childhood Cancer Day: Questions and Answers. Available at: http://www.who.int/cancer/media/news/Childhoodcancerday/en/. Accessed on 22 February, 2023.

Kolit Z, Şahin S, Davutoğlu C, Huri M. Effectiveness of a task-oriented training on occupational performance, functional independence, and fatigue in children with childhood cancer: a randomized-controlled trial. Cadernos Brasileiros de Terapia Ocupacional. 2021;29.

Muslu L, Kolutek R. Çocukluk çağı kanserleri ve sağlık okuryazarlığı. Güncel Pediatri. 2018;16(3):117-32.

Hutzen B, Ghonime M, Lee J, Mardis ER, Wang R, Lee DA et al. Immunotherapeutic challenges for pediatric cancers. Molecular Therapy-Oncolytics. 2019;15:38-48.

Erdmann F, Frederiksen LE, Bonaventure A, Mader L, Hasle H, Robison LL et al. Childhood cancer: survival, treatment modalities, late effects and improvements over time. Cancer Epidemiol. 2021;71:101733.

Sandoval JA, Malkas LH, Hickey RJ. Clinical significance of serum biomarkers in pediatric solid mediastinal and abdominal tumors. Int J Molecular Sci. 2012;13(1):1126-53.

Fish JD, Lipton JM, Lanzkowsky P. Lanzkowsky's manual of pediatric hematology and oncology. Academic Press. 2016;1.

Mutlu M, Karakaş T, Yarış N. Çocukluk çağı primer mediastinal tümörlü olguların değerlendirmesi. Tur J Pediatr. 2009;18:186-92.

Temes R, Allen N, Chavez T, Crowell R, Key C, Wernly J. Primary mediastinal malignancies in children: report of 22 patients and comparison to 197 adults. Oncologist. 2000;5(3):179-84.

Sairanen H, Leijala M, Louhimo I. Primary mediastinal tumors in children. Eur J Cardio-Thoracic Surg. 1987;1(3):148-51.

Tansel T, Onursal E, Dayıoğlu E, Başaran M, Sungur Z, Çamcı E et al. Childhood mediastinal masses in infants and children. Turk J Pediatr. 2006;48:8-12.

Freud E, Ben-Ari J, Schonfeld T, Blumenfeld A, Steinberg R, Dlugy E et al. Mediastinal tumors in children: a single institution experience. Clin Pediatr 2002;41(4):219-23.

Lam JCM, Chui CH, Jacobsen AS, Tan AM, Joseph VT. When is a mediastinal mass critical in a child? An analysis of 29 patients. Pediatr Surg Int. 2004;20(3):180-84.

Takeda SI, Miyoshi S, Akashi A, Ohta M, Minami M, Okumura M et al. Clinical spectrum of primary mediastinal tumors: a comparison of adult and pediatric populations at a single Japanese institution. J Surgical Oncol. 2003;83(1):24-30.

Grosfeld JL. Primary tumors of the chest wall and mediastinum in children. In Seminars in Thoracic and Cardiovascular Surg. 1994;6(4):235-9.

Stuart J, Simpson JS, Mann JR. Intracellular hydrogen transport systems in acute leukaemia. Bri J Haematol. 1970;19(6):739-48.

Kornberg A, Polliack A. Serum lactic dehydrogenase (LDH) levels in acute leukemia: marked elevations in lymphoblastic leukemia. Blood. 1980;56(3):351-5.

Pui CH, Dodge RK, Dahl GV, Rivera G, Look AT, Kalwinsky D et al. Serum lactic dehydrogenase level has prognostic value in childhood acute lymphoblastic leukemia. Blood. 1985;66:778-82.

Downloads

Published

2023-05-25

Issue

Section

Original Research Articles